ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) (www.biomoda.com) will present on its proprietary CyPath® diagnostic assay for the detection of early-stage cancers at OneMedPlace’s mid-year finance forum in New York on Wednesday, June 30, 2010.
